Type II CRISPR/Cas9 approach in the oncological therapy

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a prokaryotic adaptable immune mechanism used by many bacteria and archaea to protect themselves from foreign nucleic acids. This complex system can recognize and cut non-self DNA in order to provide the prokaryotic organisms a st...

Descripción completa

Detalles Bibliográficos
Autores principales: Biagioni, A., Chillà, A., Andreucci, E., Laurenzana, A., Margheri, F., Peppicelli, S., Del Rosso, M., Fibbi, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472952/
https://www.ncbi.nlm.nih.gov/pubmed/28619109
http://dx.doi.org/10.1186/s13046-017-0550-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472952/
https://www.ncbi.nlm.nih.gov/pubmed/28619109
http://dx.doi.org/10.1186/s13046-017-0550-0

Ejemplares similares